Home > Chemicals and Materials > Specialty Chemicals > Custom Synthesis > sodium starch glycolate market
Get a free sample of Sodium Starch Glycolate Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Sodium Starch Glycolate Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Sodium Starch Glycolate Market size was valued at around USD 70 million in 2022 and is anticipated to grow at a CAGR of 5.2% between 2023 and 2032. Sodium starch glycolate is a commonly used disintegrant in pharmaceutical formulations, aiding the rapid breakup of tablets into smaller particles for effective drug release.
As pharmaceutical formulations become more complex, the demand for effective disintegrants like sodium starch glycolate increases to ensure proper drug release profiles. Sodium starch glycolate is utilized in instant food products to ensure rapid dissolution and rehydration, catering to consumer preferences for convenience.
Meeting regulatory requirements for pharmaceutical and food-grade products can be challenging due to evolving standards and the need for consistent quality control. Ensuring the safety of sodium starch glycolate, especially in pharmaceuticals, is crucial. Contaminants, allergens, or impurities could lead to adverse effects. Ensuring a consistent supply of high-quality starch raw materials for sodium starch glycolate production can be challenging due to variations in crops and regions. Thus, the risks associated with Sodium starch glycolate may drive down the acceptance rate, further hampering the business growth.
DFE Pharma, BASF SE, Roquette Fr
Market size for sodium starch glycolate was USD 70 million in 2022 and will reach USD 115 million by 2032 due to the pharmaceutical industry's increasing focus on enhancing drug delivery and formulation efficiency worldwide.
Sodium starch glycolate industry from the potato product segment reached over USD 30 million in 2022 and will incur significant growth from 2023-2032 on account of the availability and cost-effectiveness of potato starch as a raw material.
U.S. sodium starch glycolate industry recorded USD 24 million in 2022 and is expected to witness appreciable growth from 2023-2032 owing to the rapidly expanding pharmaceutical industry in the region.